Ardent Health Partners (NYSE:ARDT - Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Ardent Health Partners to post earnings of $0.29 per share for the quarter. Ardent Health Partners has set its FY24 guidance at $1.23-1.37 EPS and its FY 2024 guidance at 1.230-1.370 EPS.Persons that are interested in registering for the company's earnings conference call can do so using this link.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.05. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, analysts expect Ardent Health Partners to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Ardent Health Partners Trading Down 1.4 %
NYSE:ARDT traded down $0.26 during midday trading on Wednesday, reaching $18.44. 98,605 shares of the company traded hands, compared to its average volume of 387,463. The firm has a fifty day moving average of $18.54. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.65 and a quick ratio of 1.54. Ardent Health Partners has a twelve month low of $15.00 and a twelve month high of $20.72.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Loop Capital began coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued a "buy" rating and a $18.00 price objective on the stock. Mizuho began coverage on Ardent Health Partners in a report on Monday, August 12th. They issued an "outperform" rating and a $20.00 price objective for the company. Morgan Stanley assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They set an "overweight" rating and a $27.00 target price on the stock. Royal Bank of Canada initiated coverage on Ardent Health Partners in a report on Monday, August 12th. They set an "outperform" rating and a $23.00 price target on the stock. Finally, Leerink Partnrs raised shares of Ardent Health Partners to a "strong-buy" rating in a report on Monday, August 12th. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $21.91.
Get Our Latest Stock Report on ARDT
Ardent Health Partners Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Recommended Stories
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
